Financial Architects (New Jersey)’s Vanda Pharmaceuticals VNDA Stock Holding History

Financial Architects (New Jersey)’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,000	Closed	-$57K	–	754
2020 Q2	$57K	Hold	5,000	–	–	0.01%	406
2020 Q1	$52K	Hold	5,000	–	–	0.01%	383
2019 Q4	$82K	Hold	5,000	–	–	0.02%	355
2019 Q3	$66K	Hold	5,000	–	–	0.02%	391
2019 Q2	$70K	Hold	5,000	–	–	0.01%	441
2019 Q1	$92K	Hold	5,000	–	–	0.02%	476
2018 Q4	$131K	Hold	5,000	–	–	0.03%	347
2018 Q3	$115K	Hold	5,000	–	–	0.02%	434
2018 Q2	$95K	Hold	5,000	–	–	0.02%	416
2018 Q1	$84K	Hold	5,000	–	–	0.02%	493
2017 Q4	$76K	Hold	5,000	–	–	0.01%	568
2017 Q3	$90K	Hold	5,000	–	–	0.02%	521
2017 Q2	$82K	Sell	5,000 -5,000	-50%	-$72.1K	0.01%	532
2017 Q1	$140K	Hold	10,000	–	–	0.02%	376
2016 Q4	$160K	Hold	10,000	–	–	0.04%	290
2016 Q3	$166K	Hold	10,000	–	–	0.04%	295
2016 Q2	$112K	Hold	10,000	–	–	0.03%	343
2016 Q1	$84K	Hold	10,000	–	–	0.03%	314
2015 Q4	$93K	Hold	10,000	–	–	0.04%	210
2015 Q3	$113K	Hold	10,000	–	–	0.05%	197
2015 Q2	$127K	Hold	10,000	–	–	0.05%	261
2015 Q1	$93K	Hold	10,000	–	–	0.04%	294
2014 Q4	$143K	Hold	10,000	–	–	0.06%	207
2014 Q3	$104K	Hold	10,000	–	–	0.05%	211
2014 Q2	$162K	Hold	10,000	–	–	0.08%	165
2014 Q1	$163K	Hold	10,000	–	–	0.1%	144
2013 Q4	$124K	Hold	10,000	–	–	0.07%	146
2013 Q3	$110K	Hold	10,000	–	–	0.07%	172
2013 Q2	$80K	Buy	+10,000	New	+$67.3K	0.06%	190

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Financial Architects (New Jersey)'s VNDA Position: Q3 2020 in Review

Financial Architects (New Jersey) sold out of Vanda Pharmaceuticals (VNDA) in Q3 2020, closing a stake of 5,000 shares — an estimated $57K sold.

Financial Architects (New Jersey) first reported a position in VNDA in Q2 2013 and held it in 29 quarters. The position peaked at $166K in Q3 2016. 164 funds tracked by Wall St. Rank hold VNDA as of Q3 2020.

Financial Architects (New Jersey) reported no remaining Vanda Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Financial Architects (New Jersey) sold 5,000 Vanda Pharmaceuticals shares in Q3 2020, an estimated $57K.
Financial Architects (New Jersey) first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 29 quarters.
Financial Architects (New Jersey)'s Vanda Pharmaceuticals position peaked at $166K in Q3 2016.
164 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2020, filed 9 Nov 2020.